Corvus Pharmaceuticals

-$0.10 (-4.44%) As of 4:58 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.

About CRVS

Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of oncology therapies. The firm focuses on disabling cancer’s ability to subvert immune attack by inhibiting adenosine in the tumor microenvironment and by blocking its production by tumors.

CEO
Richard A. Miller
Employees
42
Headquarters
Burlingame, California
Founded
2014

CRVS Key Statistics

Market Cap
98.49M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
313.27K
High Today
$2.25
Low Today
$2.12
Open Price
$2.25
Volume
98.92K
52 Week High
$5.74
52 Week Low
$2.07

CRVS Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 6, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure